The Latest in Leukemia, Myelodysplasia, Transplantation

Hematology News

Oral azacitidine: First maintenance therapy for AML

December 13, 2019

Hematology News

Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLL

December 10, 2019

Hematology News

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

Hematology News

FDA approves acalabrutinib for CLL, SLL treatment

November 21, 2019

Hematology News

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Hematology News

Researchers seek a way to predict cognitive deficits in children treated for ALL

November 15, 2019

Hematology News

Gene signature may help guide initial CLL treatment choice

November 14, 2019

Hematology News

Caspofungin bests fluconazole for antifungal prophylaxis in young AML patients

November 5, 2019

Hematology News

Consider renal function in TLS risk assessment of venetoclax-treated CLL

October 29, 2019

Hematology News

Hematopoietic cell transplant offers realistic cure in secondary AML

October 23, 2019

Hematology News

Exercise intolerance linked to neurocognitive dysfunction in ALL

October 22, 2019

Hematology News

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors

October 16, 2019

Hematology News

Adverse cytogenetics trump molecular risk in NPM1-mutated AML

October 15, 2019

Hematology News

Targeted agents vs. chemoimmunotherapy as first-line treatment of CLL

October 3, 2019

Hematology News

Immunotherapies under investigation in newly diagnosed B-ALL

October 1, 2019